Clinical trial reportLancet (London, England)Published
First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial
Regional connection
Verified An author affiliation on the Europe PMC record names Jefferson Health. Affiliation source
- Institution
- Jefferson Health
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Lancet (London, England)
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Endometrial Neoplasms; Neoplasm Recurrence, Local; Paclitaxel; Carboplatin; Antineoplastic Combined Chemotherapy Protocols; Quality of Life; Aged; Middle Aged; Female; Antibodies, Monoclonal, Humanized
- PubMed ID
- 42933458
- Added to directory
- Source checked